CEN Biotech, Inc. (CENBF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -335.5 Thousand | -335.5 Thousand | -340.74 Thousand | -869.35 Thousand | -1.72 Million | -2.17 Million |
| Net Income | -1.51 Million | -18.9 Million | 14.24 Million | -5.65 Million | -7.53 Million | -14.08 Million |
| Depreciation & Amortization | 489.11 Thousand | 461.7 Thousand | 435.53 Thousand | 443.19 Thousand | 439.04 Thousand | 1767.00 |
| Deferred income taxes | - | -2735.00 | -20.98 Million | 65.72 Thousand | 1.17 Million | 513.93 Thousand |
| Stock-based compensation | 552.68 Thousand | 15.39 Million | 746.3 Thousand | 1.17 Million | 682 Thousand | 9.36 Million |
| Change in working capital | -165.07 Thousand | 841.76 Thousand | 3.88 Million | 131.13 Thousand | 71.08 Thousand | -340.49 Thousand |
| Other non-cash items | 302.59 Thousand | 1.87 Million | 1.33 Million | 2.96 Million | 3.43 Million | 2.36 Million |
| Investing Cash Flow | 9937.00 | 9937.00 | -130.1 Thousand | -190 Thousand | -105.43 Thousand | -510.72 Thousand |
| Investments in PPE | -129.53 Thousand | -129.53 Thousand | - | - | -5439.00 | -160.72 Thousand |
| Acquisitions | 259.47 Thousand | 259.47 Thousand | 1801.00 | -190 Thousand | -100 Thousand | -350 Thousand |
| Investment purchases | - | -120 Thousand | -131.9 Thousand | - | - | - |
| Sales/Maturities of investments | - | 120 Thousand | - | - | - | - |
| Other Investing Activities | -120 Thousand | -120 Thousand | - | -190 Thousand | - | -350 Thousand |
| Financing Cash Flow | 520.83 Thousand | 520.83 Thousand | 469 Thousand | 1.05 Million | 1.74 Million | 2.71 Million |
| Debt repayment | -50 Thousand | -50 Thousand | -30 Thousand | -6000.00 | -423.23 Thousand | -10 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -10.00 |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 570.83 Thousand | 570.83 Thousand | 499 Thousand | 1.06 Million | 2.17 Million | 2.72 Million |
| Accounts receivables | 83.87 Thousand | 14.17 Thousand | 310.11 Thousand | -5205.00 | -196.34 Thousand | -222.56 Thousand |
| Accounts payables | 2857.00 | 182.76 Thousand | 5840.00 | -36 Thousand | 160.92 Thousand | -126.15 Thousand |
| Inventory | - | 529.78 Thousand | -310.11 Thousand | 5205.00 | - | - |
| Other working capital | -251.8 Thousand | 115.04 Thousand | 3.87 Million | 167.14 Thousand | -89.84 Thousand | -214.33 Thousand |
| Cash at beginning of period | 1908.00 | 1908.00 | 3757.00 | 3193.00 | 84.97 Thousand | 62.38 Thousand |
| Cash at end of period | 193.19 Thousand | 193.19 Thousand | 1908.00 | 3757.00 | 3193.00 | 84.97 Thousand |
| Capital Expenditure | -129.53 Thousand | -129.53 Thousand | - | - | -5439.00 | -160.72 Thousand |
| Effect of forex changes on cash | -3973.00 | -3973.00 | - | - | - | - |
| Net cash flow / Change in cash | 191.29 Thousand | 191.29 Thousand | -1849.00 | 564.00 | -81.78 Thousand | 22.59 Thousand |
| Free Cash Flow | -465.03 Thousand | -465.03 Thousand | -340.74 Thousand | -869.35 Thousand | -1.72 Million | -2.33 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 371.45 Thousand | -225.08 Thousand | -400.88 Thousand | -487.48 Thousand | -1.51 Million | -420.19 Thousand |
| Depreciation & Amortization | - | 14.38 Thousand | 14.28 Thousand | 169.17 Thousand | 489.11 Thousand | 200.88 Thousand |
| Deferred income taxes | - | - | - | - | - | -491.89 Thousand |
| Stock-based compensation | - | - | 20.6 Thousand | 406.73 Thousand | 552.68 Thousand | 145.95 Thousand |
| Change in working capital | 12.56 Thousand | 320.98 Thousand | 320.05 Thousand | -210.24 Thousand | -165.07 Thousand | -16.78 Thousand |
| Other non-cash items | 148.51 Thousand | -193.63 Thousand | 148.28 Thousand | 297.56 Thousand | 302.59 Thousand | 491.89 Thousand |
| Investing Cash Flow | -35.31 Thousand | -72.04 Thousand | -49.64 Thousand | 9937.00 | 9937.00 | - |
| Investments in PPE | -35.31 Thousand | -72.04 Thousand | -49.64 Thousand | -124.21 Thousand | -129.53 Thousand | - |
| Acquisitions | - | - | - | 259.47 Thousand | 259.47 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -125.32 Thousand | -120 Thousand | - |
| Financing Cash Flow | - | - | - | 54.32 Thousand | 520.83 Thousand | -9807.00 |
| Debt repayment | - | - | - | -50 Thousand | -50 Thousand | -80.32 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -92.56 |
| Common Stock Issuance | - | - | - | -308.19 Thousand | - | -96.47 Thousand |
| Other Financing Activities | - | - | - | 412.52 Thousand | 570.83 Thousand | 183.33 Thousand |
| Accounts receivables | 2153.72 | 19.01 Thousand | 7035.00 | -97.94 Thousand | 83.87 Thousand | 92.63 Thousand |
| Accounts payables | -102.57 Thousand | 53.07 Thousand | 210.17 Thousand | 93.95 Thousand | 2857.00 | -21.2 Thousand |
| Inventory | 0.28 | - | - | - | - | - |
| Other working capital | 112.97 Thousand | 248.89 Thousand | 102.84 Thousand | -206.25 Thousand | -251.8 Thousand | -88.21 Thousand |
| Cash at beginning of period | 24.41 Thousand | 136.28 Thousand | 83.59 Thousand | 148.15 Thousand | 1908.00 | 66.04 Thousand |
| Cash at end of period | 419.6 Thousand | 24.41 Thousand | 136.28 Thousand | 193.19 Thousand | 193.19 Thousand | 148.15 Thousand |
| Capital Expenditure | -35.31 Thousand | -72.04 Thousand | -49.64 Thousand | -124.21 Thousand | -129.53 Thousand | - |
| Effect of forex changes on cash | - | - | - | -194.96 Thousand | -3973.00 | - |
| Net cash flow / Change in cash | 395.18 Thousand | -111.87 Thousand | 52.68 Thousand | 45.04 Thousand | 191.29 Thousand | 82.1 Thousand |
| Free Cash Flow | 396.8 Thousand | -112.08 Thousand | 52.68 Thousand | 51.53 Thousand | -465.03 Thousand | -90.14 Thousand |
5312
SIRI
093370
NXPLW
9533
000001